Search research articles
Contact Us
Filters
Showing results (21-30 of 68) with videos related to
Page
of 7
Sort By:
Vaccine
|
June 1, 1984
Anthrax: the disease in relation to vaccines
P Hambleton, J A Carman, J Melling
The Journal of Applied Bacteriology
|
June 1, 1986
Scaled-up production and purification of Clostridium perfringens type A enterotoxin
D Reynolds, H S Tranter, P Hambleton
European Journal of Biochemistry
|
August 15, 1985
Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity
C C Shone, P Hambleton, J Melling
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
January 1, 1988
Approaches to the rational design of bacterial vaccines
P Hambleton, S D Prior, A Robinson
Eye (London, England)
|
January 1, 1988
Clostridium botulinum toxins: nature and preparation for clinical use
J Melling, P Hambleton, C C Shone
European Journal of Biochemistry
|
August 17, 1987
A 50-kDa fragment from the NH2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles
C C Shone, P Hambleton, J Melling
Bioseparation
|
January 1, 1992
Purification of bacterial exotoxins. The case of botulinum, tetanus, anthrax, pertussis and cholera toxins
V A Pasechnik, C C Shone, P Hambleton
Applied and Environmental Microbiology
|
July 1, 1988
Novel method for purification of staphylococcal enterotoxin A
D Reynolds, H S Tranter, R Sage, et al.
The Journal of Pathology
|
March 1, 1983
Histopathology of experimental Legionnaires' disease in guinea pigs, rhesus monkeys and marmosets
A Baskerville, R B Fitzgeorge, M Broster, et al.
The Journal of Pharmacy and Pharmacology
|
April 1, 1993
The impact of new medicines development on pharmaceutical analysis
C N Wiblin, P Hambleton, J Melling, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 68) with videos related to
Sort By:
Page
of 7
Vaccine
|
June 1, 1984
Anthrax: the disease in relation to vaccines
P Hambleton, J A Carman, J Melling
The Journal of Applied Bacteriology
|
June 1, 1986
Scaled-up production and purification of Clostridium perfringens type A enterotoxin
D Reynolds, H S Tranter, P Hambleton
European Journal of Biochemistry
|
August 15, 1985
Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity
C C Shone, P Hambleton, J Melling
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
January 1, 1988
Approaches to the rational design of bacterial vaccines
P Hambleton, S D Prior, A Robinson
Eye (London, England)
|
January 1, 1988
Clostridium botulinum toxins: nature and preparation for clinical use
J Melling, P Hambleton, C C Shone
European Journal of Biochemistry
|
August 17, 1987
A 50-kDa fragment from the NH2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles
C C Shone, P Hambleton, J Melling
Bioseparation
|
January 1, 1992
Purification of bacterial exotoxins. The case of botulinum, tetanus, anthrax, pertussis and cholera toxins
V A Pasechnik, C C Shone, P Hambleton
Applied and Environmental Microbiology
|
July 1, 1988
Novel method for purification of staphylococcal enterotoxin A
D Reynolds, H S Tranter, R Sage, et al.
The Journal of Pathology
|
March 1, 1983
Histopathology of experimental Legionnaires' disease in guinea pigs, rhesus monkeys and marmosets
A Baskerville, R B Fitzgeorge, M Broster, et al.
The Journal of Pharmacy and Pharmacology
|
April 1, 1993
The impact of new medicines development on pharmaceutical analysis
C N Wiblin, P Hambleton, J Melling, et al.
Page
of 7